Utah Medical Products (UTMD) Income from Continuing Operations (2010 - 2026)

Utah Medical Products' Income from Continuing Operations history runs 17 years deep, the most recent figure standing at 2604000.0 for Q1 2026.

• On a quarterly basis, Income from Continuing Operations fell 14.37% year-over-year to 2604000.0 in Q1 2026; TTM through Mar 2026 was 10235000.0, a 26.96% decrease from a year earlier, with the FY2025 full-year figure at 10672000.0, down 23.81% from the prior year.
• Income from Continuing Operations climbed to 2604000.0 in Q1 2026 per UTMD's latest filing, from 1952000.0 in the prior quarter.
• Across five years, Income from Continuing Operations topped out at 8251000.0 in Q4 2022 and bottomed at 3525000.0 in Q4 2023.
• The 5-year median for Income from Continuing Operations is 3534000.0 (2022), against an average of 3180000.0.
• Across the five-year window, Income from Continuing Operations jumped 204.81% in 2022 and slumped 142.72% in 2023, its largest moves.
• Year by year, Income from Continuing Operations stood at 8251000.0 in 2022, then tumbled by 142.72% to 3525000.0 in 2023, then surged by 123.26% to 820000.0 in 2024, then jumped by 138.05% to 1952000.0 in 2025, then soared by 33.4% to 2604000.0 in 2026.
• Per Business Quant, the three latest UTMD Income from Continuing Operations figures stand at 2604000.0 (Q1 2026), 1952000.0 (Q4 2025), and 2631000.0 (Q3 2025).